MedPath

Dialectic Therapeutics, Inc.

Dialectic Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2018-01-01
Employees
1
Market Cap
-
Website
http://www.dtsciences.com

A Study of DT2216 in Relapsed/Refractory Malignancies

Phase 1
Completed
Conditions
Solid Tumor
Hematologic Malignancy
Interventions
First Posted Date
2021-05-14
Last Posted Date
2025-04-16
Lead Sponsor
Dialectic Therapeutics, Inc
Target Recruit Count
20
Registration Number
NCT04886622
Locations
🇺🇸

Mays Cancer Center, San Antonio, Texas, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

Mary Crowley Cancer Research, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath